Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis

IntroductionRemyelination of demyelinated axons can occur as an endogenous repair mechanism in multiple sclerosis (MS), but its efficacy varies between both MS individuals and lesions. The molecular and cellular mechanisms that drive remyelination remain poorly understood. Here, we studied the relat...

Full description

Saved in:
Bibliographic Details
Main Authors: J. Q. Alida Chen, Dennis D. Wever, Niamh B. McNamara, Morjana Bourik, Joost Smolders, Jörg Hamann, Inge Huitinga
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1522381/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841540169713319936
author J. Q. Alida Chen
Dennis D. Wever
Niamh B. McNamara
Morjana Bourik
Joost Smolders
Jörg Hamann
Jörg Hamann
Inge Huitinga
Inge Huitinga
author_facet J. Q. Alida Chen
Dennis D. Wever
Niamh B. McNamara
Morjana Bourik
Joost Smolders
Jörg Hamann
Jörg Hamann
Inge Huitinga
Inge Huitinga
author_sort J. Q. Alida Chen
collection DOAJ
description IntroductionRemyelination of demyelinated axons can occur as an endogenous repair mechanism in multiple sclerosis (MS), but its efficacy varies between both MS individuals and lesions. The molecular and cellular mechanisms that drive remyelination remain poorly understood. Here, we studied the relation between microglia activation and remyelination activity in MS.MethodsWe correlated regenerative (CD163+) and inflammatory (iNOS+) microglia with BCAS1+ oligodendrocytes, subdivided into early-stage (<3 processes) and late-stage (≥3 processes) cells in brain donors with high or low remyelinating potential in remyelinated lesions and active lesions with ramified/amoeboid (non-foamy) or foamy microglia. A cohort of MS donors categorized as efficiently remyelinating donors (ERDs; n=25) or poorly remyelinating donors (PRDs; n=17) was included, based on their proportion of remyelinated lesions at autopsy.Results and discussionWe hypothesized more CD163+ microglia and BCAS1+ oligodendrocytes in remyelinated and active non-foamy lesions from ERDs and more iNOS+ microglia with fewer BCAS1+ oligodendrocytes in active foamy lesions from PRDs. For CD163+ microglia, however, no differences were observed between MS lesions and MS donor groups. In line with our hypothesis, we found that INOS+ microglia were significantly increased in PRDs compared to ERDs within remyelinated lesions. MS lesions, more late-stage BCAS1+ oligodendrocytes were detected in active lesions with non-foamy or foamy microglia in comparison with remyelinated lesions. Although no differences were found for early-stage BCAS1+ oligodendrocytes between MS lesions, we did find significantly more early-stage BCAS1+ oligodendrocytes in PRDs vs ERDs in remyelinated lesions. Interestingly, a positive correlation was identified between iNOS+ microglia and the presence of early-stage BCAS1+ oligodendrocytes. These findings suggest that impaired maturation of early-stage BCAS1+ oligodendrocytes, encountering inflammatory microglia, may underlie remyelination deficits and unsuccessful lesion repair in MS.
format Article
id doaj-art-07efa34de4074da3adbd08ca1cd6bb71
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-07efa34de4074da3adbd08ca1cd6bb712025-01-14T05:10:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.15223811522381Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosisJ. Q. Alida Chen0Dennis D. Wever1Niamh B. McNamara2Morjana Bourik3Joost Smolders4Jörg Hamann5Jörg Hamann6Inge Huitinga7Inge Huitinga8Neuroimmunology Research Group, Netherlands Institute for Neuroscience, Amsterdam, NetherlandsNeuroimmunology Research Group, Netherlands Institute for Neuroscience, Amsterdam, NetherlandsNeuroimmunology Research Group, Netherlands Institute for Neuroscience, Amsterdam, NetherlandsNeuroimmunology Research Group, Netherlands Institute for Neuroscience, Amsterdam, NetherlandsDepartments of Neurology and Immunology, MS Center ErasMS, Erasmus MC, University Medical Center, Rotterdam, NetherlandsNeuroimmunology Research Group, Netherlands Institute for Neuroscience, Amsterdam, NetherlandsDepartment of Experimental Immunology, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam University Medical Center, Amsterdam, NetherlandsNeuroimmunology Research Group, Netherlands Institute for Neuroscience, Amsterdam, NetherlandsSwammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, NetherlandsIntroductionRemyelination of demyelinated axons can occur as an endogenous repair mechanism in multiple sclerosis (MS), but its efficacy varies between both MS individuals and lesions. The molecular and cellular mechanisms that drive remyelination remain poorly understood. Here, we studied the relation between microglia activation and remyelination activity in MS.MethodsWe correlated regenerative (CD163+) and inflammatory (iNOS+) microglia with BCAS1+ oligodendrocytes, subdivided into early-stage (<3 processes) and late-stage (≥3 processes) cells in brain donors with high or low remyelinating potential in remyelinated lesions and active lesions with ramified/amoeboid (non-foamy) or foamy microglia. A cohort of MS donors categorized as efficiently remyelinating donors (ERDs; n=25) or poorly remyelinating donors (PRDs; n=17) was included, based on their proportion of remyelinated lesions at autopsy.Results and discussionWe hypothesized more CD163+ microglia and BCAS1+ oligodendrocytes in remyelinated and active non-foamy lesions from ERDs and more iNOS+ microglia with fewer BCAS1+ oligodendrocytes in active foamy lesions from PRDs. For CD163+ microglia, however, no differences were observed between MS lesions and MS donor groups. In line with our hypothesis, we found that INOS+ microglia were significantly increased in PRDs compared to ERDs within remyelinated lesions. MS lesions, more late-stage BCAS1+ oligodendrocytes were detected in active lesions with non-foamy or foamy microglia in comparison with remyelinated lesions. Although no differences were found for early-stage BCAS1+ oligodendrocytes between MS lesions, we did find significantly more early-stage BCAS1+ oligodendrocytes in PRDs vs ERDs in remyelinated lesions. Interestingly, a positive correlation was identified between iNOS+ microglia and the presence of early-stage BCAS1+ oligodendrocytes. These findings suggest that impaired maturation of early-stage BCAS1+ oligodendrocytes, encountering inflammatory microglia, may underlie remyelination deficits and unsuccessful lesion repair in MS.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1522381/fullmultiple sclerosisremyelinationinflammationmicrogliaoligodendrocytes
spellingShingle J. Q. Alida Chen
Dennis D. Wever
Niamh B. McNamara
Morjana Bourik
Joost Smolders
Jörg Hamann
Jörg Hamann
Inge Huitinga
Inge Huitinga
Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
Frontiers in Immunology
multiple sclerosis
remyelination
inflammation
microglia
oligodendrocytes
title Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
title_full Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
title_fullStr Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
title_full_unstemmed Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
title_short Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
title_sort inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
topic multiple sclerosis
remyelination
inflammation
microglia
oligodendrocytes
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1522381/full
work_keys_str_mv AT jqalidachen inflammatorymicrogliacorrelatewithimpairedoligodendrocytematurationinmultiplesclerosis
AT dennisdwever inflammatorymicrogliacorrelatewithimpairedoligodendrocytematurationinmultiplesclerosis
AT niamhbmcnamara inflammatorymicrogliacorrelatewithimpairedoligodendrocytematurationinmultiplesclerosis
AT morjanabourik inflammatorymicrogliacorrelatewithimpairedoligodendrocytematurationinmultiplesclerosis
AT joostsmolders inflammatorymicrogliacorrelatewithimpairedoligodendrocytematurationinmultiplesclerosis
AT jorghamann inflammatorymicrogliacorrelatewithimpairedoligodendrocytematurationinmultiplesclerosis
AT jorghamann inflammatorymicrogliacorrelatewithimpairedoligodendrocytematurationinmultiplesclerosis
AT ingehuitinga inflammatorymicrogliacorrelatewithimpairedoligodendrocytematurationinmultiplesclerosis
AT ingehuitinga inflammatorymicrogliacorrelatewithimpairedoligodendrocytematurationinmultiplesclerosis